『Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients』のカバーアート

Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients

Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients

著者： Annenberg Center for Health Sciences
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 The combined developmental and epileptic encephalopathy of Dravet syndrome provides significant diagnostic and treatment challenges. This activity focuses on key characteristics and clinical presentations of Dravet syndrome with the aim of early identification of persons with the syndrome, timely initiation and appropriate use of approved medications, and the need for a multidisciplinary care plan, particularly as individuals transition into adulthood. Dr. Wirrell also provides an overview of investigational disease-modifying therapies.Annenberg Center for Health Sciences 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Disease-Modifying Therapies

    Disease-Modifying Therapies
    2026/04/29
    • Antisense oligonucleotide– zorevunersen
    • Histamine antagonist– clemizole hydrochloride
    • Serotonin agonist– bexicaserin
    • Gene therapy– ETX101
    続きを読む 一部表示
    13 分
  • Optimizing Standards of Care

    Optimizing Standards of Care
    2026/04/29
    • Seizure management–cannabidiol, fenfluramine, stiripentol; ketogenic diet
    • Multidisciplinary care
    • Dravet Syndrome Foundation Transition Guide
    • Seizure action plan
    続きを読む 一部表示
    20 分
  • Improving Diagnosis

    Improving Diagnosis
    2026/04/29
    • Key features and triggers
    • Imaging
    • DS mimics
    • Genetic testing
    続きを読む 一部表示
    8 分
まだレビューはありません